Edward A. Mule, 10% Owner (NONE), bought 330,000 shares at $12.43 ($4.1M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Open-market purchase of $4.1M NONE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateKeenova Therapeutics plc | BUY | 2026-01-09 | $23.1M | — | Filing → |
| GPOR | SELL |
| 2025-12-03 |
| $127.4M |
| — |
| Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-05-22 | $18.5M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | SELL | 2025-05-22 | $56.5M | — | Filing → |
| GPOR | SELL | 2025-05-15 | $267.7M | — | Filing → |